Peak assignments for Raman spectra of hUC-MSCs. Abbreviations: asym, asymmetric; symm, symmetric; str, stretching; def, deformation; bk, backbone; A, Adenine; G, Guanine; C, Cytosine; T, Thymine; U, Uracil; Phe: phenylalanine; Tyr: tyrosine; Trp: tryptophan.
As a burgeoning research area, stem cells’ unique self-renewal and multilineage differentiation capability have quickly attracted the attention of scientists and researchers worldwide. Promising applications of stems cells include repairing and regenerating diseased or aged tissues and organs, restoring impaired body functions, and providing new treatments to various diseases.
One member in the stem cell family that deserves special mention is human umbilical cord derived mesenchymal stem cells (hUC-MSC). Great clinical application value and broad industrial development prospect of hUC-MSC have been recognized due to its large differentiation potential, strong proliferation capability, low immunogenicity, source variety, convenient availability, free of ethical restriction, and easy production in industry. Obviously, these unique features of stem cells rely on various factors including their biological composition, structure, and cell viability. The viability decrease, apoptosis, or necrosis of stem cells will seriously lead to the variation or even loss of their functions. Therefore, a key step in the production and quality control of stem cells is to accurately monitor the status of stem cells and their viability in real time. Research in this field has shown great importance in not only fundamental study of stem cell biology, but also research, development, and clinical use of stem cell drugs.
Although contemporary cell biology has provided a number of ways to acquire the information on the status of the cells, these methods are often invasive. Relevant biochemical reactions, dyeing, marking, fixation, cell lysis, and other treatments could remarkably induce the change of the environment necessary for cell growth and the normal physiological function of the cells. These biological techniques could even destroy the structures of the cells, leading to irreversible cell damage or necrosis. As a result, biology-based methods can hardly meet the requirements for the production and quality control of stem cells.
Raman spectroscopy has prominent advantages over biological methods due to its high sensitivity to changes inside biological systems and influences from external environment. Also, it plays non-destructively on the cells. These distinguished features make Raman spectroscopy a superior choice in the study of high spatial resolution and real time monitoring of stem cells.
In this chapter, we will first introduce the basic concepts and theories of light absorption and scattering, and Raman scattering. Then, the change of the stem cell viability and its related mechanisms studied by Raman spectroscopy will be described in detail. Finally, a summary of our overall work will be given.
2. Basic concept and elementary theory
2.1. Scattering and light scattering
Scattering is a phenomenon widely seen in nature. When the incident particles collide with target particles, the incident particles interact with the target particle making the incident particles deviating from the incident direction and even changing its energy. This phenomenon is known as scattering. Analyzing the interactions of matters and their internal structures and movements by scattering has become an important tool in both macro and micro worlds.
Scattering of light is often observed in our daily lives. For example, when the light passes through a homogeneous and transparent matter such as glass and water, we cannot notice the light path from the side. However, if the media is inhomogeneous or contains impurities (like liquid with suspended particles or gels), the light beam can be clearly observed in the medium. This results from the scattering of light.
In the 19th century, the study of light scattering was focused on liquid and gas, which are widespread in nature. Based on the causes, the scatterings are classified as Tyndall scattering and molecular scattering. British physicist Lord Rayleigh studied the intensities of scattered molecular light. In 1871, he proposed that the intensity of scattered light is inversely proportional to the fourth powers of the wavelength (λ4). He proposed that the intensity of scattered light is inversely proportional to the fourth powers of the wavelength, which is known as the famous Rayleigh scattering law. In 1908, C. Mie found that the intensity of scattered light in Tyndall scattering is not inversely proportional to the fourth powers of the wavelength, which is in contrary to molecular scattering. Therefore, Tyndall scattering is also called Mie scattering.
Since the 20th century, the study of light scattering reached deeply into the levels of atoms, electrons, and quasi-particles. Researchers began to pay attention to the energy change of the scattered light relative to the incident light (i.e., the wavelength change). It was found that the wavelength variation of the scattered light relative to the incident light corresponds to different scattering mechanisms. The types of light scattering are thus classified. In the study of light scattering, the unit of energy is commonly the wave numbers (cm-1).When the wave number change is less than 10-5 cm-1, the scattering is called Rayleigh scattering. Wave number change of about 0.1 cm-1 is called Brillouin scattering. More than 1 cm-1 wave number change is known as Raman scattering. If the wavelength / energy of the scattered light does not change relative to the incident light, it is elastic scattering, otherwise is non-elastic scattering. Obviously, the latter two types of scattering are non-elastic scattering. The wave number change in Rayleigh scattering is caused by the rebound of the target particles, and therefore Rayleigh scattering is elastic scattering.
2.2. Raman scattering
Raman spectroscopy is a scattering spectroscopy that concerns the vibrational and rotational energy levels of the molecules. It is a useful tool for the analysis of molecular structure, with advantages of being non-destructive and without the need of special ways to prepare the samples. Compared with the infrared absorption spectroscopy, water shows extremely weak Raman signals. Thus for most samples in water, the noise from water can be greatly reduced. Raman spectroscopy can also record signals from different samples in the same time, and these signals do not interfere with each other. With the developments of laser technology and weak signal detection technology, Raman spectroscopy as an effective method to study the structure of matter, will find wide and practical applications in various fields including chemistry, physics, biology, and medicine.
From the basic perspective of quantum theory, Raman scattering can be considered as an inelastic process as a result of the collisions between photons and molecules. When the incident photons collide with molecules, molecules interact with the photons and then absorb the photon energies. Molecules are thus excited into a virtual state. Since this virtual state is not stable, molecules immediately radiate photons and release energy. If the energy of the photon radiation is smaller than that of the incident photon, Stokes shift will be observed (Fig.2a). If the energy of photon radiation is larger than that of the incident photon, anti-Stokes shift will be recorded (Fig.2b). If the energy of photon radiation is equal to that of the incident photon, Rayleigh scattering will be produced (Fig.3). Since Raman scattering concerns the energy difference between the incident and scattered photons, this energy difference is associated with the corresponding vibration levels of the molecules.
Since each substance has rich vibration levels, Raman spectra carry a lot of information about the materials. Known as the fingerprint spectrum, Raman spectroscopy is of great significance to the analysis and identification of the components of materials.
3. Detecting viability transitions of umbilical cord mesenchymal stem cells by Raman micro-spectroscopy
Mesenchymal stem cells (MSCs) are pluripotent progenitor cells derived from the mesoderm. They are particularly attractive in cell/gene therapy for tissue regeneration and cancer therapy  for their own specific properties, including multi-differentiation potential, hematopoietic-supporting activity, immunomodulatory potency, and self-renewal. The major source of MSCs is bone marrow. However, the clinical use of bone marrow-derived MSCs is limited due to the relatively invasive sample collection procedure, and a significant reduction in cell number, proliferation, and differentiation capacity with age or age-related diseases. Recent advances suggest that human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) could be an alternative source ideal for MSCs due to the relative ease of collection, safety, and abundance of human umbilical cord [2-5].
Our group has developed a standard procedure to acquire hUC-MSCs and established the first hUC-MSCs bank in China. Our intensive studies on the possible clinical application of this type of cells suggest that they can work as a promising candidate for cell-based therapy because of their young age and low infection rate compared to MSCs in adult tissues [6-9]. A large population of hUC-MSCs sustained in high viability condition is fundamental to successful cell-based therapy. Therefore, monitoring the cellular state transitions is an important step for the population expansion and quality assurance of these cells.
Currently, a number of methods including biological assays and optical techniques are available to handle this task. For example, laser scanning confocal fluorescence microscopy has been used to image living cells. However, the introduction of exogenous fluorescence labels is always a problem in the cell viability maintenance. On the contrary, Raman spectroscopy is a label-free, vibration spectroscopy-based technique that has been used to illustrate the intrinsic molecular structure and composition of biological samples. It has the potential to provide new and unique optical markers for cytological analysis in recent years [10-18]. At the present time, this technique has been increasingly used in the studies of stem cells. Notingher et al. monitored the differentiation of embryonic stem cells (ESCs) by recording the intensity of Raman peaks of nucleic acids as differentiation markers . Chan et al. demonstrated that cell identification and classification were achieved using Raman scattering of the intrinsic biochemical signature for individual human embryonic stem cells (hESCs) . More recently, Chiang and co-workers successfully applied Raman spectroscopy to monitor and quantitatively evaluate the differentiation of hMSCs into osteoblasts .
Here, the Raman micro-spectroscopy is used to find the molecular vibrations that are sensitive to the viability change of hUC-MSCs. The Raman spectra of hUC-MSCs with different cellular states were investigated, and the spectral differences between the cells with high viability (> 90%) and low viability (< 20%) were quantified using peak fitting and statistic t-test. It is found that the Raman peaks at 744, 877, and 1342 cm-1 show the most obvious changes as the cell viability decreases: the former two peaks, which correspond respectively to the vibration of C=O out-of-the-plane bending in Thymine and the symmetric stretching of C-C in lipids, are both roughly doubled; however, the latter peak, which corresponds to C-H deformation in proteins, is reduced by ca. 30%.
hUC tissues were collected from voluntary donors, the healthy parturient women with well-developed fetus, who signed the consent form informed beforehand. The collection followed proper procedures according to the regulations of the Research Ethics Committees of the Chinese Academy of Medical Sciences and Beijing Union Medical College. The hUC tissues were then minced into 1mm3 small fragments with sharp scissors. The fragments were washed thoroughly with PBS to remove contamination, and then treated with 0.075% collagenaseII and 0.25% trypsin (Sigma) at 37 oC for 30 min. The digested mixture was passed through a 200µm filter to obtain cell suspensions. The dissociated cells were washed twice with PBS, planted on uncoated 25cm2 culture flasks, and then cultured in Dulbecco’s modified Eagle’s medium with low gluocose (DMEM-LG/F-12, DF12; Gibco) and 10% Fetal bovine serum (FBS, USA). The culture medium was replaced 2 days first and then after every 3 or 4 days. Daily progress of the cell culturing was monitored by phase-contrast microscopy. The cells were serially passaged and expanded in a humidified incubator at 37 oC with 5% CO2.
hUC-MSCs with different viability were used for experiments. Decrease of the cell viability was induced by placing the cells under a condition of starvation, i.e. suspending in PBS at a low temperature of 4 oC for several days. The cell viability was accessed using the Trypan blue method in parallel with the Raman spectral measurements. The viability is defined as the ratio of the number of viable cells to the total number of all cells, and we call > 90% viability as “high viability” while < 20% viability as low viability.
The Raman spectra of hUC-MSCs with different viability were recorded using a Raman micro-spectrometer (LabRAM HR800, HORIBA Jobin Yvon, France), which is equipped with a 632.8 nm helium-neon laser for excitation. By means of the microscopic imaging provided by a TV camera, the Raman spectrum of each cell was measured by focusing the laser beam in the center of the cell. Under the laser power of 17 mW with a 50× objective, the signal was integrated for 100 s. Each Raman spectrum was recorded in the range of 600-1800 cm−1.
For spectral preprocessing, the background signal was subtracted from each spectrum, and a multipoint baseline was corrected in the whole spectral region. Spectra were then normalized to the peak intensity at 1448 cm−1 according to ref.  and .
In order to quantitatively characterize the Raman peaks, peak fitting was carried out in the spectral regions that show obvious differences between the cells with high and low viability by using the PeakFit software (v4.12, SeaSolve Software Inc., USA). The peak shape was taken to be Gaussian.
To statistically compare the intensity difference peak by peak, the Student’s t-test was performed on each fitted Raman peak for two cell-groups (one group of 22 hUCMSCs with high viability and the other of 20 with low viability). The p values obtained from the t-test are used as the indicators of the differences. Since the p value is defined as the probability of making a wrong judgment about a difference between the two sets of data, the smaller p value implies the existence of the difference with higher possibility. As a rule of thumb, when p<0.05 the difference is meant to be statistical significance.
5. Experimental results
Fig. 4 shows the average Raman spectra of hUC-MSCs, where curve “a” is for high viable cells and curve “b” for low viable cells. The Raman spectra show small standard deviations among the cells with the same viability (as presented as the gray shadows in curve “a” and “b”). As can be seen, there are several Raman peaks that are already discernable, i.e. the 1448 cm
A Raman peak, which is uniquely defined by its spectral parameters including Raman shift, intensity, and full width at half maximum (FWHM), reveals the information about a specific molecular vibration. In order to extract the Raman peaks in the spectral regions where the high viable cells and low viable ones are distinguishing, the peak fitting analysis was performed. Fig. 5 shows the fitting results of curve “a” and “b” in Fig.4, and Table 1 provides the extended peak assignments.
It can be seen from Fig. 5 that when the cell viability decreases, no obvious changes in Raman shift and FWHM are observed. However, the variations in peak intensity can be observed clearly. Apparently, as the cell viability decreases, the intensities of peaks at lower Raman shift (
As mentioned in this paper, the peak intensity could be a signature for indicating the cell viability transitions. And the correlation with the peak intensity and the cell viability has been proved by our studies. To understand it further, the possible causes of the peak intensity changes are discussed briefly here. As been shown in Table 1, the Raman spectra of hUC-MSCs are contributed from all major biological macromolecules including nucleic acids, proteins, lipids and carbohydrates. The intensity changes of the Raman peaks, especially for those highly sensitive to the cell viability transitions, can be understood from the interaction model between the intracellular reactive oxygen species (ROS, such as
In healthy cells, ROS are typically generated at controlled rates. In contrast, the production of ROS will be elevated under stress conditions (e.g. cell apoptosis). This elevation will result in changes of many cellular components, such as DNA, proteins, and lipids, which will lead to further influence on the cell viability, metabolism, and growth. In addition to the findings shown in this paper, new research results from our lab on hUC-MSCs show that about half of the cells with low viability appear to be apoptotic (these results will be published elsewhere). As mentioned above, a large amount of ROS will stack in this situation. There were results suggesting that the excessive ROS will introduce attacks on intracellular biomolecules such as nucleic acids, proteins, and lipids . So we believe that the peak intensity changes can be explained by the effect of excessive ROS, as follows. Because excessive ROS destroy the base-base stacking interactions, the hyperchromicity occurs resulting in the increasing intensity of Raman peaks, which correspond to nucleic acid bases at 744, 667, 643, and 621 cm
In this study, we have shown that the relative intensity of Raman peaks at 1342, 877, and 744 cm−1, which correspond respectively to C-H deformation in proteins, C–C symmetric stretching in lipids, and C=O out-of-the-plane bending in Thymine, are highly sensitive to the changes of hUC-MSCs viability. The intensity decrease of the peak at 1342 cm−1 and the intensity enhancement of the peaks at 877 and 744 cm−1 in the cells with low viability are related to the alterations of the secondary structures of proteins, the degradation of proteins, the structural modification of lipids, and the destruction of base-base stacking interactions in DNA. These changes could be understood by the interactions between the excessive intracellular ROS and the biomolecules.
|621||A 5-member ring deformation|
|643||T ring angle bend|
|667||G ring breath|
|719||CN+(CH3)3 str in lipids|
|732||A ring breath|
|744||T C=O out of plane bend|
|758||Trp ring breath|
|784||O-P-O str of DNA|
|811||O-P-O str of RNA|
|827||Tyr out of plane ring breath|
|853||Tyr ring breath|
|877||C-C symm str in lipids|
|934||C-C bk str in proteins|
|980||=CH bend in lipids|
|1003||Phe symm ring breath|
|1010||C-O str in deoxyribose|
|1064||Chain C-C str in lipids|
|1083||C-N str in proteins; Chain C-C str in lipids; C-O str in carbohydrates|
|1127||C-N,C-C str in proteins|
|1157||C-C,C-N str in proteins|
|1209||C-C6H5 str of Phe|
|1231||Amide III random coil|
|1242||Amide III β-sheet|
|1258||Amide III β-sheet|
|1284||Amide III α-helix|
|1301||CH2 twist in lipids|
|1320||G; CH def in proteins|
|1342||CH def in proteins|
|1364||CH3 symm str in lipids|
|1448||CH def in DNA/RNA, proteins, lipids and carbohydrates|
|1659||Amide I α-helix|
7. Relations between Reactive Oxygen Species and Raman Spectral Variations of Human Umbilical Cord Mesenchymal Stem Cells with Different Viability
Mesenchymal stem cells (MSCs) are particularly attractive in cell-based therapy because of their distinct immunosuppressive properties and multi-differentiation capacity [27,28]. MSCs are traditionally found in the bone marrow. However, they can also be isolated from other tissues such as human umbilical cord. Human umbilical cord-derived MSCs (hUC-MSCs) have shown similar or even superior properties compared to bone marrow derived MSCs (BM-MSCs) including plastic adherence, specific surface markers, regenerative capability, collection convenience, safety, and potential of in vitro differential in certain lineages [29,30]. As a result of these advantages, hUC-MSCs have gained more attention in recent years.
Currently, hUC-MSCs are being explored as a promising candidate for therapeutic applications. Wu and Zhou [31,32] discussed the therapeutic potential of hUC-MSCs in cardiomyocyte regeneration, and their findings demonstrated that transplanted hUC-MSCs provide benefit in the restoration of cardiac function, suggesting that hUC-MSCs represent a source of stem cells for cell therapy and myocardial tissue engineering. Liao et al. reported that hUC-MSCs treatment could be an ideal strategy for cell-based therapy for central nervous system injury and disease . Moreover, the impact of hUC-MSCs on liver fibrosis was also observed by Han and co-workers . Recently, a series of experimental results indicate that hUC-MSCs are exceptional candidates for muscle repair , bone tissue engineering  and the treatment of rheumatoid arthritis (RA) .
The above data indicate that the hUC-MSCs hold great promise as therapeutic agents and as a tool for understanding the development of regeneration medicine. It is known that a large population of cells with high viability is fundamental to a successful cell-based therapy. Therefore, the detection of cell viability changes represents a key step for the population expansion and quality assurance of hUC-MSCs. As a label-free method, Raman spectroscopy is increasingly used in the study of stem cells [10, 19-21]. In our recently work , this technology was used to detect the viability transitions of hUC-MSCs. An encouraging finding was that the most significant Raman spectral variations associated with the cell viability decrease were at 1342, 877, and 744 cm−1, which implied a great potential for characterizing the cell viability changes. Considering the biochemical effects involved in the reactions of reactive oxygen species (ROS) , we concluded that these Raman spectral changes are probably due to the interaction between the intracellular ROS and biological macromolecules. However, given the diversity of cellular components and the complexity of molecular interactions, the reasons and the mechanisms of the Raman spectral variations remain unclear. In this context, several studies in our group are being carried out with the purpose of providing insights into the role of ROS involved in the cell viability transitions.
As an important aspect, the dependence of the Raman spectral variations on the yield of ROS in the cells has been studied in this paper. Here, we employ a ROS probe (DCFH-DA) to monitor the change of intracellular ROS level in hUC-MSCs as their viability declines. In addition, the Raman spectra of the cells with different viability are also recorded by Raman micro-spectroscopy. The results show that as the cell viability declines, the relative intensity variations of Raman peaks at 1342, 877, and 744 cm−1, and the relative yield variation of ROS in cells can be described by a same model(with different fitting parameters). Moreover, the correlations of these relative changes were evaluated by correlation coefficient method. It is found that they have perfect linear correlation coefficients respectively. This study further demonstrates that the relative yield variation of the ROS in hUC-MSCs with different viability can directly cause the relative intensity variation of Raman spectra in the cells.
7.1. Intracellular ROS measurement
The relative levels of ROS in hUC-MSCs with different viability were accessed using 2',7'-dichlorofluorescin diacetate (DCFH-DA, Sigma), a fluorescent probe for intracellular ROS measurement. The DCFH-DA itself is non-fluorescent. It can be easily diffused through the cell membrane and be hydrolyzed by intracellular esterases to produce non-fluorescent 2',7'-dichlorofluorescin (DCFH), which can no longer pass through the membrane so that the probe can easily be loaded into the cells. DCFH is then oxidized by ROS to generate fluorescent 2',7'-dichlorofluorescein (DCF), whose fluorescence intensity is proportional to the amount of intracellular ROS [37, 38]. The cells were suspended in PBS at a density of 5.5 × 105 cells/mL. After DCFH-DA was suspended at a final concentration of 20μmol/L, the cells were incubated for 40 min at 37°C for probe loading. -DCF fluorescence was then measured by a spectrometer (SpectraPro 300i, Acton, USA) equipped with a CCD detector (Spec-10, PI, USA). Ar+ laser (488 nm) was used for excitation, and the fluorescence was recorded in the range of 510–600 nm. In addition, same measurements of the DCFH-DA and PBS mixture (final concentration of the probe: 20 μmol/L) without cells for fluorescent background acquisition were also performed.
7.2. Experimental results
ROS consist of a series of oxygen free radicals and their derivatives, such as O2-, H2O2, and OH, possess active chemical properties and high oxidation capability. They are generated from the sequential univalent reduction of oxygen involved in the cell metabolism [39, 40]. Since the cell itself has a highly efficient antioxidant system for eliminating ROS, the production and scavenging of ROS maintain a dynamic equilibrium under normal conditions. An appropriate amount of ROS is associated with many important physiological functions, such as biological messengers involved in cellular signal transduction [41, 42]. However, the production of intracellular ROS will greatly exceed the cellular antioxidant capacity under oxidative stress . And ROS can act as the toxicants that easily react with biomolecules to damage their structures and functions and change their physical and chemical properties as Raman scattering [43–45].
Thus, to explore whether ROS play a role in the Raman spectral variations associated with the hUC-MSCs’ viability transitions, we first monitored the change of intracellular ROS level as the cell viability decreased. As shown in Fig. 7, under the condition of cell starvation, the cell viability exhibits a linear decline with time. Therefore, the changes of the ROS level and the Raman spectra in cells as the cell viability decreases can be measured and discussed in the time dimension. By using ROS probe (DCFH-DA), the intracellular ROS levels were observed by the fluorescence spectra of the probe at different times. The results are shown in Fig. 8. The fluorescence spectra are from DCF, which is produced by the reactions of the probes with ROS. No fluorescence signals can be detected in the mixture solution of the probe molecules and PBS without the cells (“Background” in Fig. 8A), indicating that the fluorescence is originated only from the interaction of the probes with the intracellular ROS but not self-oxidation of the probes. Therefore, the relative intensities (F) of the fluorescence in Fig. 8A will be directly proportional to the ROS level (ROS) in cells [37, 38] under the experimental conditions we designed. The relationship can be expressed as follows
where ε is the proportional constant in this case. Fig. 8B shows the column diagram of the relative fluorescence intensity at different times based on Fig. 8A. It is apparent that as the viability decreases, the level of ROS increases initially. It reaches a maximum value about 1.5 times higher than the initial time (t = 0) as the viability drops to about 36%. As the viability continues to decrease, the ROS level experiences a decline.
As mentioned above, a low ROS level under normal conditions is beneficial to the cells. Few oxidative damages by ROS should be taken into consideration in this case. However, when the production of ROS exceeds the cellular antioxidant capacity, oxidative damages will occur . In other words, the excessive intracellular ROS lead to the oxidative damages. Considering this, we calculate the relative variation of ROS level (ΔROS(t)) in the cells at each measurement time t based on the data in Fig. 8B, and take the first relative intensity at initial time (t = 0) as a normal value in the cells with normal viability. Therefore, the ΔROS(t) (t is the measurement time in Fig. 8B) can be calculated by the following expression.
where F(t) and F(0) represent the relative fluorescence intensity at time t and the initial time (t = 0), respectively. The change of ΔROS with time is shown by the black squares in Fig. 9.
Based on the data shown in Fig. 9, we seek to find a mathematical model to describe their change with time. It is found that a rational function (shown in Eq. (3)) can make a good fitting with the fitting degree R2 = 0.983. Thus, the ΔROS(t) can generally be expressed by the rational function as follows.
The data in Fig. 9 show that the ROS level is always higher than the initial (t = 0) in our observation period, implying that an accumulation of the excessive ROS in cells may occur as the cell viability decreases.
It should be noted that according to our experimental methods, the DCF fluorescence intensity is proportional to the amount of ROS generated in a short time period (40 min), which can be considered as a time point when compared to the entire experimental period (7 days). Thus, the data presented in Fig. 9 can only show the variation of “transient” ROS level, but not the yield of ROS during the cell viability decline. Since the oxidative damages resulting from excessive ROS can be irreversible , they thus rely on the cumulative effect of excessive ROS reacting with biomolecules. This means that the oxidative damages depend in part on the yield variation of ROS as the cell viability decreases. Having this in mind, we estimate the relative yield variation of ROS by integrating Eq. (3).
Calling the values of the parameters (a, b, c, d) from the best fitting result in Fig. 9 and considering the integral upper and lower limits, we can estimate the relative yield variation of ROS at any time point. The estimated ΔROSyield(t) at t = 0d, 1d, 2d, …, 6d is shown in Fig. 10, which exhibits a nonlinear increase with time. In particular, it is found that the change of ΔROSyield(t) can be exactly described by the logistic model (Eq. (6)) as indicated by the fitting degree R2 = 0.999. This model describes an S-type growth, i.e., the growth gradually slows down and eventually stops when the time goes to infinity.
The above results show that the relative yield variation of intracellular ROS increases continuously with the cell viability drop, suggesting that excessive ROS accumulate in cells and thus may attack the biomolecules as expected.
The excessive ROS are capable of attacking biomolecules, such as proteins, nucleic acids, and lipids, by a variety of reaction mechanisms including hydrogen abstraction, addition, etc. [40, 46, 47]. For example, ROS can react directly with the amino acid residues, causing the inactivation and denaturation of proteins . Their attacks on DNA can also lead to the DNA bases modification and breaking of chemical bonds and certain strands [39, 47]. In addition, ROS induce the peroxidation of unsaturated fatty acids and cause oxidative damage to lipids [39, 40]. This reaction is also an important mechanism that occurs with the oxidative damage to other biomolecules, such as malondialdehyde, an intermediate of peroxidation, that can cause the cross-linking of proteins [40, 46]. The oxidative damages from these reactions will undoubtedly lead to the structural and functional alterations of the biomolecules, and thus may cause changes in their Raman scattering.
Here we will pay attention to the dependence of the Raman spectral changes on ROS, but not the types of oxidative reactions that lead to the changes. That is, the relationship between Raman spectral variations and the relative yield variation of ROS in the cells need to be examined further in this paper. Raman spectra of hUC-MSCs with different viability (or at different time points) are shown in Fig. 11A. Raman spectral variations as the cell viability declines can be observed clearly. Thus we choose three vibration peaks that have been proven to be sensitive to the hUC-MSCs viability transitions . They are protein C-H deformation at 1342 cm–1, lipid C–C symmetric stretching at 877 cm–1, and thymine C=O out-of-the-plane bending at 744 cm–1. Their relative intensity changes as a function of time are shown in Fig. 11B. It can be seen that the relative intensity of 1342 cm–1 decreases with time, while those of 877 and 744 cm–1 exhibit the reverse orientation. Further, we will focus on the variation of the relative intensity, because any deviations of these characteristic peak intensities from their normal values will indicate the drop of cell viability .
Based on the data shown in Fig. 11b and the above method used to discuss ROS (Eq. (2)), the relative peak intensity variations (ΔIw(t)) of the three peaks can be calculated by the following expression.
where Iw(t) and Iw(0) represent the relative intensity of the peak w at the time t and the initial time (t = 0), respectively. The calculated results are shown in Fig. 12.
To investigate the change tracks of ΔI1342(t), ΔI877(t), ΔI744(t) and their relationship to ΔROSyield(t), we also try to use the logistic model (Eq. (6)) to fit the data points in Fig.12. As presented in Fig. 12, it is interesting to find that the logistic model is also suitable for describing the changes of ΔI1342(t), ΔI877(t), and ΔI744(t) indicated by the high fitting degrees of 0.993, 0.986, and 0.996, respectively. However, the parameters (α, β, γ) obtained by fitting ΔI1342(t), ΔI877(t), and ΔI744(t) differ from each other, and also show large differences from those of fitting ΔROSyield(t). This seems reasonable and understandable from the complexity and diversity of ROS reactions. There are many mechanisms showing that ROS interact with biomolecules directly or indirectly [40, 46, 47]. The attack of ROS seems impossible to cause the synchronous and homogeneous alterations in all the biomolecules. The differences in the molecular response (rate, scale, sensitivity) to the ROS attack and the types of reactions will inevitably affect the reaction rates (of the reactant depletion and the product formation) in the cells. And also, the formation of the excessive ROS themselves will lead to the component changes in the cells. All complications make the fitting parameters or the fitting curves of ΔIw(t) of some individual Raman peaks w show larger deviation from those of ΔROSyield(t). That is, it is almost impossible for all ΔIw(t) to correlate with ΔROSyield(t) in exact linearity. Furthermore, it should be mentioned that the parameter α is primarily determined by the maximum of the relative intensity (or yield) variation and is basically independent on the fitting curves that is defined by the shape parameters β and γ. The differences between ΔI744(t) and ΔROSyield(t) in the two shape parameters are the largest (Fig. 12C) in all the ΔIw(t), thus the linear correlation between their fitting curves is the lowest, suggesting that the reaction mechanism relating to this peak increase would be very complicated. In fact, the ROS in the cells are consumed through many channels. Therefore, we may have a better result if using the sum of the relative intensity variations of all characteristic Raman peaks (here we have three peaks) measured at the same time. The relative intensity total variation as a function of time (ΔItotal(t)) is expressed as follows.
where ΔIw(t) is the relative intensity variation of the peak w at time t. Here we have w = 1342, 877, and 744 cm–1. The calculated results are shown in Fig. 12d, and the fitting curve (with Eq. (6)) shows a perfect fitting degree (R2 = 0.999). All the fitting constants for ΔItotal(t) are much better than those for any other ΔIw(t) compared with those for ΔROSyield(t). Thus, the fitting curves of ΔItotal(t) and ΔROSyield(t) are basically similar, and the linear relationship between them should be better than others.
To further quantitatively evaluate the relationship, the correlation coefficient r is employed to describe the correlations of ΔI1342(t), ΔI877(t), ΔI744(t), and ΔItotal(t) with ΔROSyield(t), respectively. The r is calculated as follows .
where, Xi, Yi (i = 1, 2, …, n) express independent and dependent variables respectively; r describes the linear correlation of the two variables and takes the value in –1 ≤ r ≤ 1. The larger |r| is, the higher the correlation will be. The calculation results show that the correlation coefficients for correlated ΔI1342(t), ΔI877(t), ΔI744(t), and ΔItotal(t) to ΔROSyield(t) are 0.980, 0.985, 0.973, and 0.987, respectively. For clarity, these correlations are shown in Fig. 13. The high |rw| values provide a further evidence to confirm that the changes of the three relative peak intensities linearly correlate to the relative yield variation of ROS, especially at the beginning of the cell viability decrease. Taken together, the results demonstrate that the oxidative damages induced by excessive intracellular ROS lead to the Raman spectral variations associated with the cell viability decline. In addition, the ΔItotal(t) shows the best linear relationship to the ΔROSyield(t), while that of individual Raman peak intensity appears lower linear correlation coefficient, indicating that the corresponding biochemical reactions of intracellular ROS have much more complicate mechanisms and needs further study.
Herein, we reveal that the relative yield variation of ROS in hUC-MSCs with different viability can directly lead to the relative intensity variations of the three characteristic Raman peaks at 1342, 877, and 744 cm–1 in the cells, according to their perfect linear correlation coefficients of 0.980, 0.985, and 0.973, respectively. Our findings demonstrate that the excessive intracellular ROS can result in the almost linear variation of the relative Raman peak intensity in hUC-MSCs as the cell viability declines. These results would be very useful for understanding the mechanisms of Raman spectral changes in the cells.
Mesenchymal stem cells (MSCs) are pluripotent progenitor cells derived from the mesoderm. They are particularly suitable for cell-based therapy because of their different immunosuppressive properties and multi-differentiation capacity. The main source of MSCs is bone marrow. In addition, recent progress revealed that human umbilical cord derived mesenchymal stem cells (hUC-MSCs) could be an alternative source ideal for MSCs. Comparing to bone marrow-derived MSCs (BM-MSCs), hUC-MSCs have exhibited similar or even superior properties such as plastic adherence, specific surface markers, regenerative capability, collection convenience, safety, and potential for in vitro differential in certain lineages. These advantages make hUC-MSCs a promising candidate for therapeutic applications in recent years.
As is known, a large population of cells in sustained high profitability is fundamental to successful cell-based therapy. Therefore, monitoring the variation in cell viability is an important step for the population expansion and quality assurance of hUC-MSCs. Right now there are a number of methods including biological assays and optical techniques available to handle this task. Among these techniques, Raman spectroscopy is a label-free method that allows for continued analysis. Moreover, it is proven that Raman spectroscopy has the potential to offer new and unique optical markers for cytological analysis. Currently this technology is increasingly used in the studies of stem cells.
In this work, Raman micro-spectroscopy is used to monitor the variation of hUC-MSCs viability. The Raman spectra of hUC-MSCs with different cellular states are investigated. Using peak fitting and statistical t-test, the Raman peaks are extracted with obvious differences between cells of different viability. Most significant changes (p <0.001) have been found for the out-of-plane bending of C=O in thymine at 744cm-1, symmetric stretching of C-C in lipids at 877cm-1, and deformation of C-H in proteins at 1342cm-1. As the cell viability decreases, the intensity of the peak at 1342cm-1 is reduced, whereas those of the peaks at 877 and 744 cm-1 are enhanced. Based on these results, we propose that the viability of hUC-MSCs can be characterized by these three peaks.
Given the biochemical effects involved in the reactions of reactive oxygen species (ROS), we conclude that the changes of Raman peak intensity could be explained by the interactions between excessive intracellular ROS and biological macromolecules. However, considering the diversity of cellular components and the complexity of molecular interactions, the exact reasons and mechanisms remain unclear. In this context, we further investigate the dependence of the Raman spectral variations on the yield of ROS in the cells for understanding the mechanism. Here we employ a ROS probe (DCFH-DA) to monitor the change of intracellular ROS level in hUC-MSCs as their viability declines. The results we obtained show that as the cell viability decreases, the relative intensity variations of the Raman peaks at 1342 cm-1, 877 cm-1, and 744 cm-1, and the relative yield variations of ROS in cells can be described by the same model function (besides different fitting parameters used). In addition, the correlations of these relative changes were assessed by correlation coefficient method. Perfect linear correlation coefficients of 0.969, 0.982, and 0.975 were found. Our results further demonstrate that the relative yield variations of ROS in hUC-MSCs with different viability directly cause the relative intensity variations of Raman spectra in the cells. The results would be very useful for understanding the mechanism of the Raman spectral changes in the cells and the investigation of the basis for the application of Raman scattering in the measurement of stem cell viability.
We would like to thank Prof. Y. Zhao and Mrs. L.W. Duan for assistance in Raman spectral measurements. This work is supported by Tianjin Municipal Science and Technology Commission (No. 08ZCDFGX09400), and National Natural Science Fund Committee of China (No. 60508004 and No. 60778043).
otaln H. C. Schichor Lah T. T. 2010Human mesenchymal stem cells and their use in cell-based therapies. Cancer 116:2519-2530 (2010)
Mitchell K. E. M. L. BM Weiss Mitchell. P. Martin D. Davis L. Morales B. Helwig M. Beerenstrauch K. Abou-Easa T. Hildreth D. Troyer Medicetty S. 2003Matrix cells from Wharton’s jelly form neurons and glia. Stem Cells 21:50-60 (2003).
Wang HS, SC Hung, ST Peng, CC Huang, HM Wei, YJ Guo, YS Fu, MC Lai and CC Chen. 2004Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord. Stem Cells 22:1330-1337 (2004).
Sarugaser R. D. Lickorish D. MM Baksh Hosseini. Davies J. E. 2005Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells 23:220-229 (2005).
Baksh D. R. Yao Tuan R. S. 2007Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25:1384-1392 (2007).
Li G. X. A. Zhang H. Wang X. Wang C. L. Meng C. Y. Chan D. T. W. Yew K. S. Tsang K. Li S. N. Tsai S. M. Ngai Z. C. Han M. C. Lin M. L. He Kung H. F. 2009Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: Implication in the migration. Proteomics 9:20-30 (2009).
Therapeutic benefit of human umbilical cord derived mesenchymal stromal cells in intracerebral hemorrhage rat: Implications of anti-inflammation and angiogenesis. Cell Physiol Biochem 24:307-316 ( Liao W. B. J. Zhong J. X. Yu J. Xie Y. J. Liu L. Du S. G. Yang P. X. Liu J. Xu J. M. Wang Z. B. Han Han Z. C. 2009
Human umbilical cord derived stem cells for the injured heart. Med Hypotheses 68:94-97 ( Wu K. H. S. G. Yang B. Zhou W. T. DS Du Gu. P. X. Liu W. B. Liao Z. C. Han Liu Y. L. 2007
Lu L. L. Y. J. Liu S. G. Yang Q. J. Zhao X. Wang W. Gong Z. B. Han Z. S. Xu Y. X. Lu D. Liu Z. Z. Chen Han Z. C. 2006Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91:1017-1026 (2006).
Chan JW and DK Lieu. 2009Label-free biochemical characterization of stem cells using vibrational spectroscopy. J Biophotonics 2:656-668 (2009).
Spectroscopic study of human lung epithelial cells (A549) in culture: Living cells versus dead cells. Biopolymers 72:230-240 ( Notingher I. S. Verrier S. Haque J. M. Polak Hench L. L. 2003
Notingher I. G. Jell U. Lohbauer V. Salih Hench L. L. 2004In situ non-invasive spectral discrimination between bone cell phenotypes used in tissue engineering. J Cell Biochem 92:1180-1192 (2004).
Verrier S. I. Notingher J. M. Polak Hench L. L. 2004In situ monitoring of cell death using Raman microspectroscopy. Biopolymers 74:157-162 (2004).
Raman spectroscopy detects biochemical changes due to proliferation in mammalian cell cultures. Biophys J 88:4274-4288 ( Short K. W. S. Carpenter J. P. Freyer Mourant J. R. 2005
CA Owen J. Selvakumaran I. Notingher G. Jell L. L. Hench MM Stevens 2006In vitro toxicology evaluation of pharmaceuticals using Raman micro-spectroscopy. J Cell Biochem 99:178-186 (2006).
Swain RJ and MM Stevens.Raman microspectroscopy for non-invasive biochemical analysis of single cells. Biochemical Society Transactions 35:544-549 ( 2007
Swain R. J. G. Jell MM Stevens 2008Non-invasive analysis of cell cycle dynamics in single living cells with Raman micro-spectroscopy. J Cell Biochem 104:1427-1438 (2008).
Raman spectroscopy and microscopy of individual cells and cellular components. Laser & Photon Rev 2:325-349 ( Chan J. S. Fore S. Wachsmann-Hogiu Huser T. 2008
Notingher I. I. Bisson J. M. Polak Hench L. L. 2004In situ spectroscopic study of nucleic acids in differentiating embryonic stem cells. Vib Spectrosc 35:199-203 (2004).
Label-free separation of human embryonic stem cells and their cardiac derivatives using Raman spectroscopy. Anal Chem 81:1324-1331 ( Chan J. W. D. K. Lieu T. Huser Li R. A. 2009
Chiang HK, FY Peng, SC Hung and YC Feng. 2009In situ Raman spectroscopic monitoring of hydroxyapatite as human mesenchymal stem cells differentiate into osteoblasts. J Raman Spectrosc 40:546-549 (2009).
Probing the effect of an extract of elk velvet antler powder on mesenchymal stem cells using Raman microspectroscopy: Enhanced differentiation toward osteogenic fate. J Raman Spectrosc 37:480-486( Azrad E. D. Zahor R. Vago Z. Nevo R. Doron D. Robinson L. A. Gheber S. Rosenwaks Bar I. 2006
Mohamed T. A. I. A. Shabaan W. M. Zoghaib J. Husband R. S. Farag MA Abd-Nasser El Alajhaz. 2009Tautomerism, normal coordinate analysis, vibrational assignments, calculated IR, Raman and NMR spectra of adenine. J Mol Struct 938:263-276 (2009).
Singh, J.S. 2008FTIR and Raman spectra and fundamental frequencies of biomolecule: 5Methyluracil (thymine). J Mol Struct 876:127-133 (2008).
Raman diagnosis of nucleic acid structure: Sugar-puckering and glycosidic conformation in the guanosine moiety. Nucleic Acids Res 11:1579-1588 ( Nishimura Y. M. Tsuboi T. Nakano S. Higuchi T. Sato T. Shida S. Uesugi E. Ohtsuka Ikehara M. 1983
Beckman KB and BN Ames.The free radical theory of aging matures. Physiol Rev 78:547-581 ( 1998
- 27. A. J. Nauta and W. E. Fibbe, Immunomodulatory properties of mesenchymal stromal cells, Blood 110, 3499-3506 (2007).
J. Immunol. 36, Uccelli A. Moretta L. Pistoia V. Immunoregulatory function. of mesenchymal. stem cells. Eur 2566 EOF 73 EOF 2006
Knocaefe C. Balci D. Hayta B. B. Can A. Reprogramming of. human umbilical. cord stromal. mesenchymal stem. cells for. myogenic differentiation. muscle repair. Stem Cells. Rev 2010
Immunol. 135, 448-458 ( Chen K. Wang D. Du W. T. Han Z. B. Ren H. Chi Y. Yang S. G. Zhu D. L. Bayard F. Han Z. C. Human umbilical. cord mesenchymal. stem-M cells. h. U. C. Cs S. exert immunosuppressive. activities through. a. P. G. E 2-dependent mechanism. Clin 2010
Thorac. Surg. 83, Wu K. H. Zhou B. Yu C. T. Cui B. Lu S. H. Han Z. C. Liu Y. L. Therapeutic potential. of human. umbilical cord. derived stem. cells in. a. rat myocardial. infarction model. Ann 1491 EOF 1498 EOF 2007
Cell. Biochem. 107, Wu K. H. Mo X. M. Zhou B. Lu S. H. Yang S. G. Liu Y. L. Han Z. C. Cardiac potential. of stem. cells from. whole human. umbilical cord. tissue J. 926 EOF 932 EOF 2009
Ren H. Y. Zhao Q. J. Cheng T. Lu S. H. Chen Z. Meng L. Zhu X. F. Yang S. G. W. Xiao Y. D. Ren Q. Chi Y. Gu D. S. Yang R. C. Han Z. C. 2010No contribution of umbilical cord mesenchymal stromal cells to capillarization and venularization of hepatic sinusoids accompanied by hepatic differentiation in carbon tetrachloride-induced mouse liver fibrosis, Cytotherapy 12, 371-383 (2010).
Zhao L. Burguera E. F. Xu H. H. K. Amin N. Ryou H. Arola D. D. 2010Fatigue and human umbilical cord stem cell seeding characteristics of calcium phosphate-chitosan-biodegradable fiber scaffolds, Biomaterials 31, 840-847 (2010).
Liu Y. Y. Mu R. Wang S. Y. Long L. Liu X. Li R. Sun J. Guo J. P. Zhang X. P. Guo J. Yu P. Li C. L. Liu X. Y. Huang Z. Y. Wang D. P. Li H. Gu Z. F. Liu B. Li Z. G. 2010Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis, Arthritis Res. Ther. 12, R210 (2010).
Bai H. Chen P. Fang H. Lin L. Tang G. Q. Mu G. G. Gong W. Liu Z. P. Wu H. Zhao H. Han Z. C. 2011Detecting viability transitions of umbilical cord mesenchymal stem cells by Raman micro-spectroscopy, Laser Phys. Lett. 8, 78-84 (2011).
Choi S. I. Jeong C. S. Cho S. Y. Lee Y. S. 2007Mechanism of apoptosis induced by apigenin in HepG2 human hepatoma cells: involvement of reactive oxygen species generated by NADPH oxidase, Arch. Pharm. Res. 30, 1328-1335 (2007).
Shen H. M. Shi C. Y. Shen Y. Ong C. N. 1996Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B1, Free Radic. Biol. Med. 21, 139-146 (1996).
Bandyopadhyay U. Das D. Banerjee R. K. 1999Reactive oxygen species: Oxidative damage and pathogenesis, Curr. Sci. 77, 658-666 (1999).
Yin D. Chen K. 2005The essential mechanisms of aging: Irreparable damage accumulation of biochemical side-reactions, Exp. Gerontol. 40, 455-465 (2005).
D’Autréaux B. Toledano M. B. 2007ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis, Nat. Rev. Mol. Cell Biol. 8, 813-824 (2007).
Gomes A. Fernandes E. Lima J. L. F. C. 2005Fluorescence probes used for detection of reactive oxygen species, J. Biochem. Biophys. Methods 65, 45-80 (2005).
Chang W. T. Lin H. L. Chen H. C. Wu Y. M. Chen W. J. Lee Y. T. Liau L. 2009Real-time molecular assessment on oxidative injury of single cells using Raman spectroscopy, J. Raman Spectrosc. 40, 1194-1199 (2009).
Zhang D. M. Jiang D. P. Yanney M. Zou S. Sygula A. 2009Ratiometric Raman spectroscopy for quantification of protein oxidative damage, Anal. Biochem. 391, 121-126 (2009).
Xu Y. M. Zhou Z. X. Yang H. Y. Xu Y. Zhang Z. Y. 1999Raman spectroscopic study of microcosmic photodamage of the space structure of DNA sensitized by Yangzhou haematoporphyrin derivative and Photofrin II, J. Photochem. Photobiol. B: Biol. 52, 30-34 (1999).
Li G. L. Yin D. Z. 2007Chem. Life 27 516 520in Chinese)
Dizdaroglu M. Jaruga P. Birincioglu M. Rodriguez H. 2002Free radical-induced damage to DNA: mechanisms and measurement, Free Radic. Biol. Med. 32, 1102-1115 (2002).
Liu Y. Chen P. Zhang F. Lin L. G. Tang Q. G. Mu G. 2009Laser Phys. Lett. 6, 465.